LAVA VIRAT SERIES GOES OUT OF STOCK ON DAY 1 OF SALE GOING LIVE ON FLIPKART

Lava International Limited, India's leading homegrown smartphone brand, confirmed a stockout of its latest Lava Virat V1 5G and Lava Virat V1 on Flipkart on Day 1 of the sale going live at 12:00 PM IST. The Lava Virat series witnessed a phenomenal response, clocking its fastest stockout on a sale day, underlining the growing base of online-first consumers who demand devices that combine dependable performance, a clean Android experience, and reliable build quality at accessible price points.

Built for India’s youth and digital-first consumers, the Lava Virat V1 5G features a 17.13 cm (6.75-inch) HD+ display with a smooth 120Hz refresh rate, a powerful 6000mAh battery, and the UNISOC T8200 processor. The smartphone comes with 4GB RAM with up to 4GB of additional virtual RAM, 64GB internal storage expandable up to 1TB, a 13MP AI Dual Camera, and a 5MP selfie camera. It runs on Clean Android 16, free from ads and bloatware, and comes with IP64-rated dust and water resistance.

 The Lava Virat V1 is powered by a 5000mAh battery and the UNISOC SC9863A processor, and features a 17.13 cm (6.75-inch) HD+ display. With 4GB RAM with up to 4GB of additional virtual RAM, 64GB internal storage expandable up to 256GB, a 13MP AI Dual Rear Camera, and a 5MP selfie camera, the smartphone offers reliable everyday performance. It also features a clean Android experience with no ads and no bloatware, along with IP64 dust and water resistance.

Lava is currently working closely with Flipkart to replenish stocks at the earliest, ensuring that consumers who missed out in the first round will be able to purchase the device soon.

Comments

Post a Comment

Popular posts from this blog

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

Image
  Bharat Petroleum Corporation Limited (BPCL) dealer network has rolled out its festive season campaign, “Fuelling the Festive Spirit”, from 22nd September to 31st October 2025 across 3,000 Retail Outlets in Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu.   Customers fuelling up with eligible transactions can win exciting prizes of 17 car and  83 Bikes through QR-based digital  slogan context participation. BPCL spokesperson said, “Festivals in India are a time of joy, giving, and togetherness. With ‘Fuelling the Festive Spirit,’ we are delighted to reward our customers and empower our frontline teams, making every visit to our retail outlets during this festive season truly memorable.”
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Gleneagles Hospital Successfully Treats Rare CNS (Brain) Lymphoma with Advanced CAR-T Cell Therapy

Image
Gleneagles Hospital Chennai, a part of Fortis Healthcare, has successfully treated a 49-year-old patient from Andhra Pradesh diagnosed with a rare and aggressive form of CNS(brain) lymphoma using advanced CAR-T cell therapy. Despite developing multiple serious treatment-related complications, the patient achieved complete remission and is doing well. The patient presented with complaints of persistent headache, giddiness, difficulty in walking, and weakness in his left arm and leg. Detailed investigations confirmed Primary Central Nervous System Lymphoma (PCNSL) , a rare type of lymphoma that affects the brain and is known to be difficult to treat. The patient initially received high-dose chemotherapy, the standard first-line treatment for this condition. However, the disease continued to progress despite four cycles of treatment. He subsequently underwent radiotherapy with chemotherapy, followed by oral targeted therapy as bridging treatment. As the lymphoma remained resistant to ...
Read more